bioAffinity Technologies (BIAFW) News Today → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free BIAFW Stock Alerts $0.39 +0.04 (+11.43%) (As of 05/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023investorplace.com - April 2 at 12:01 AMbioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - April 1 at 2:06 PMbioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lungfinance.yahoo.com - March 5 at 12:07 PMbioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directorsfinance.yahoo.com - December 5 at 8:55 AMbioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Postfinance.yahoo.com - November 28 at 8:32 AMbioAffinity Technologies files for a $25M mixed shelf offeringmsn.com - November 16 at 7:37 PMbioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conferencefinance.yahoo.com - October 10 at 9:00 AMbioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Servicesfinance.yahoo.com - September 19 at 12:52 PMbioAffinity Technologies Inc. Wtwsj.com - September 15 at 11:44 PMbioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - August 14 at 5:32 PMAMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancerfinance.yahoo.com - July 12 at 9:59 AMbioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposiumfinance.yahoo.com - June 15 at 8:43 AMbioAffinity Technologies Presents Research Findings at CYTO 2023finance.yahoo.com - May 22 at 8:44 AMbioAffinity Technologies, Inc. Rings the Nasdaq Stock Market Closing Bellnasdaq.com - April 7 at 10:47 PMbioAffinity Technologies, Inc. Rings the Closing Bellnasdaq.com - April 7 at 10:47 PMAfter launching IPO, promising SA biotech still chasing profitabilitybizjournals.com - April 4 at 10:35 AMbioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023finance.yahoo.com - March 24 at 10:15 AMbioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communicationsfinance.yahoo.com - February 13 at 9:54 AMBioAffinity Technologies Shares Rise 8% After Getting Notice to Allow U.S. Patentmarketwatch.com - January 4 at 6:26 PMbioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meetingfinance.yahoo.com - December 1 at 7:07 PMbioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - November 14 at 8:44 AMbioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Boardfinance.yahoo.com - November 10 at 4:25 PMbioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and Australiafinance.yahoo.com - October 25 at 9:47 AMbioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conferencefinance.yahoo.com - October 12 at 8:20 AMbioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6Mfinance.yahoo.com - September 28 at 9:31 AMbioAffinity Technologies, Inc. Warrant (BIAFW)nasdaq.com - September 27 at 1:27 PMbioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONEfinance.yahoo.com - September 14 at 8:55 AM Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAFW and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision. Start streaming it now at no cost here BIAFW Media Mentions By Week BIAFW Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIAFW News Sentiment▼0.000.38▲Average Medical News Sentiment BIAFW News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIAFW Articles This Week▼00▲BIAFW Articles Average Week Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAFW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: STRRP News Today ACONW News Today DRTSW News Today ALVO News Today AONC News Today ARTLW News Today BCTXW News Today BFRGW News Today CCLDP News Today CCLDO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIAFW) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.